Last edition
News about
Mankind Pharma Urges Greater Kidney Health Awareness as CKD Burden Rises
On World Kidney Day, Mankind Pharma highlights rising cases of Chronic Kidney Disease in India and stresses early screening, lifestyle changes and awareness to prevent late-stage diagnosis.
Eli Lilly Commits USD 3 Billion To Expand China Manufacturing
Eli Lilly and Company plans to invest USD 3 billion in China over the next decade to expand its local manufacturing and supply chain capabilities as it prepares for potential demand for new diabetes and obesity treatments.
WHO Unveils Three Product Profiles For Next-Generation Antibiotics
The World Health Organization has released three new Target Product Profiles (TPPs) aimed at guiding the development of antibacterial medicines to combat drug-resistant bacteria responsible for severe infections such as bloodstream infections, pneumonia, urinary tract infections and meningitis.
MiNK Therapeutics collaborates with C-Further consortium to develop PRAME-targeted TCR-engineered iNKT cell therapy for paediatric cancers, aiming to deliver innovative immunotherapy options for children with limited treatment alternatives.
Phase IIa MAST trial of EnteroBiotix’s microbiome therapy EBX-102-02 completes enrolment of 50 patients undergoing allogeneic stem cell transplantation to assess microbiome restoration and transplant outcomes.
Immunic Secures European Patent for Vidofludimus Calcium, Strengthening Long-Term Market Exclusivity
Immunic receives European patent protection for Vidofludimus Calcium dosing regimens, reinforcing intellectual property coverage and potentially extending exclusivity for the multiple sclerosis therapy in Europe until 2043.
Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities
Agilent Advanced Therapeutics offers CDMO services spanning oligonucleotides, microbial fermentation, complex chemistry, bioreagents, highly potent APIs, and cell line development, providing integrated end-to-end support from discovery and process development to clinical and commercial manufacturing.
Serum Institute and Bavarian Nordic Expand Partnership for Chikungunya Vaccine Manufacturing
Bavarian Nordic and Serum Institute of India have expanded their strategic partnership through a chikungunya vaccine manufacturing agreement, enabling full technology transfer and supporting future supply to low- and middle-income countries while opening opportunities for further co-development.
Hutchmed Initiates Tazverik Recall In China After Ipsen Withdraws Drug In US
Hutchmed (China) Limited has begun withdrawing the cancer therapy Tazverik (tazemetostat) from markets in mainland China, Hong Kong and Macau after its partner Ipsen decided to voluntarily remove the drug from the US market.
API Exports Reach INR 41,500 Crore, Overtake Imports In FY25
India’s exports of active pharmaceutical ingredients (APIs) exceeded imports in the financial year 2024–25, reflecting the country’s strengthening capabilities in bulk drug manufacturing.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy